A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
Clinical trial NCT04526132 · COMPLETED
Trial details
- NCT number
- NCT04526132
- Sponsor
- Shijiazhuang Yiling Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-25
- Primary completion
- 2021-12-29
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.